We help you configurate your Sooma tDCS-unit.
Sooma tDCS system offers the following configuration possibilities:
- Output current: Default 2,0 mA. Range 0-3,0 mA (0,1 mA steps)
- Stimulation duration: Default 30 mins. Range 0-60 (30 second steps)
- Mode: Active, Sham
- Treatment lock (15 sessions): OFF, ON
- Language: EN, DE, FR, IT, SP, PT, SE or FL
Using mild and non-invasive neuromodulation, Sooma tDCS™ adds a new dimension to the clinical routine for treating patients with major depression or chronic pain. This treatment is gentle and very well tolerated. It can be used as an alternative to or in combination with psychotherapy, pharmaceuticals, and other neuromodulation treatments.
Sooma tDCS™ is a class IIa medical device CE approved for treatment of Major Depressive Disorder, Fibromyalgia, and Neuropathic pain. It is an effective and easy-to-use solution for professionals, designed for routine clinical use in co-operation with leading psychiatrists and neurophysiologists.
Please note that Sooma tDCS is sold only to medical professionals. If you are a patient wishing to receive tDCS treatment, please ask your physician.
Neurofeedback Partner Shop is the official sales partner for Sooma in Germany. If you have any questions about the Sooma product line, please feel free to contact us:
Tel.: +49 89 82 03 07 74
E-Mail: info@neurofeedback-partner.de
Sooma Oy is a Finnish medical device company developing non-invasive brain stimulation devices for treatment of neurological and psychiatric disorders. Since its establishment in 2013, Sooma has been working closely with leading experts in psychiatry and clinical neurophysiology.
